Szydlo R - Search Results

1

Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia.

Dickinson AM, Pearce KF, Norden J, O'Brien SG, Holler E, Bickeböller H, Balavarca Y, Rocha V, Kolb HJ, Hromadnikova I, Sedlacek P, Niederwieser D, Brand R, Ruutu T, Apperley J, Szydlo R, Goulmy E, Siegert W, de Witte T, Gratwohl A. Dickinson AM, et al. Among authors: szydlo r. Haematologica. 2010 Jun;95(6):922-7. doi: 10.3324/haematol.2009.016220. Epub 2010 Mar 19. Haematologica. 2010. PMID: 20305143 Free PMC article.

2

HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.

Marks DI, Hughes TP, Szydlo R, Kelly S, Cullis JO, Schwarer AP, Mackinnon S, Apperley J, Barrett AJ, Hows JM, et al. Marks DI, et al. Among authors: szydlo r. Br J Haematol. 1992 Jul;81(3):383-90. doi: 10.1111/j.1365-2141.1992.tb08244.x. Br J Haematol. 1992. PMID: 1390211

3

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party.

Barrett AJ, Locatelli F, Treleaven JG, Gratwohl A, Szydło R, Zwaan FE. Barrett AJ, et al. Among authors: szydlo r. Br J Haematol. 1991 Dec;79(4):567-74. doi: 10.1111/j.1365-2141.1991.tb08083.x. Br J Haematol. 1991. PMID: 1772778 Clinical Trial.

4

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A. van Rhee F, et al. Among authors: szydlo rm. Bone Marrow Transplant. 1997 Oct;20(7):553-60. doi: 10.1038/sj.bmt.1700933. Bone Marrow Transplant. 1997. PMID: 9337056 Free article.

5

Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse.

Savage DG, Szydlo RM, Chase A, Apperley JF, Goldman JM. Savage DG, et al. Among authors: szydlo rm. Br J Haematol. 1997 Oct;99(1):30-5. doi: 10.1046/j.1365-2141.1997.3453159.x. Br J Haematol. 1997. PMID: 9359498 Free article.

6

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors.

van Rhee F, Savage D, Blackwell J, Orchard K, Dazzi F, Lin F, Chase A, Bungey J, Cross NC, Apperley J, Szydlo R, Goldman JM. van Rhee F, et al. Among authors: szydlo r. Bone Marrow Transplant. 1998 May;21(10):1055-61. doi: 10.1038/sj.bmt.1701224. Bone Marrow Transplant. 1998. PMID: 9632281

7

A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation.

Stocchi R, Szydlo R, Craddock C, Kanfer E, Apperley JF, Goldman JM, Ward KN. Stocchi R, et al. Among authors: szydlo r. Bone Marrow Transplant. 1999 Apr;23(7):705-9. doi: 10.1038/sj.bmt.1701629. Bone Marrow Transplant. 1999. PMID: 10218848

8

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

Dazzi F, Szydlo RM, Goldman JM. Dazzi F, et al. Among authors: szydlo rm. Exp Hematol. 1999 Oct;27(10):1477-86. doi: 10.1016/s0301-472x(99)00096-x. Exp Hematol. 1999. PMID: 10517488 Free article. Review.

9

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia.

Dazzi F, Szydlo RM, Craddock C, Cross NC, Kaeda J, Chase A, Olavarria E, van Rhee F, Kanfer E, Apperley JF, Goldman JM. Dazzi F, et al. Among authors: szydlo rm. Blood. 2000 Jan 1;95(1):67-71. Blood. 2000. PMID: 10607686 Free article. Clinical Trial.

10

High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: a single-centre experience.

Olavarria E, Kanfer E, Szydlo R, O'Brien S, Craddock C, Apperley J, Goldman J. Olavarria E, et al. Among authors: szydlo r. Br J Haematol. 2000 Mar;108(4):769-77. doi: 10.1046/j.1365-2141.2000.01905.x. Br J Haematol. 2000. PMID: 10792282 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters